ACCURAY INCORPORATED Proceeds from Sale and Maturity of Marketable Securities
ACCURAY INCORPORATED (ARAY) reported Proceeds from Sale and Maturity of Marketable Securities of $30.32 million for the 12-month period ending 2018-06-30, per its 10-K filed 2020-08-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2020-08-25
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for the quarter ending 2018-06-30 was $440.00K.
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for the quarter ending 2018-03-31 was $23.88M, a 59.28% increase year-over-year.
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for the quarter ending 2017-03-31 was $14.99M, a 7.42% decline year-over-year.
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for fiscal 2018 was $30.32M, a 20.60% decline from fiscal 2017.
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for fiscal 2017 was $38.18M, a 52.68% decline from fiscal 2016.
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for fiscal 2016 was $80.68M, a 33.48% decline from fiscal 2015.
- ACCURAY INCORPORATED proceeds from sale and maturity of marketable securities for fiscal 2015 was $121.30M, a 87.83% increase from fiscal 2014.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2018-06-30 | $440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-25 | $24.32M derived: sum of 2 quarters · filed 2020-08-25 | $30.32M 10-K · filed 2020-08-25 | |
| 2018-03-31 | $23.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | $29.88M 10-Q · filed 2019-05-09 | ||
| 2017-12-31 | $6.00M 10-Q · filed 2019-02-08 | |||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | $14.99M derived: sum of 2 quarters · filed 2019-08-23 | $22.80M derived: sum of 3 quarters · filed 2019-08-23 | $38.18M 10-K · filed 2019-08-23 |
| 2017-03-31 | $14.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-02 | $22.80M derived: sum of 2 quarters · filed 2018-05-02 | $38.18M 10-Q · filed 2018-05-02 | $73.17M derived: sum of 4 quarters · filed 2018-08-24 |
| 2016-12-31 | $7.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-05 | $23.19M 10-Q · filed 2018-02-05 | $58.18M derived: sum of 3 quarters · filed 2018-08-24 | $74.37M derived: sum of 4 quarters · filed 2018-08-24 |
| 2016-09-30 | $15.38M 10-Q · filed 2017-11-03 | $50.37M derived: sum of 2 quarters · filed 2018-08-24 | $66.56M derived: sum of 3 quarters · filed 2018-08-24 | $84.07M derived: sum of 4 quarters · filed 2018-08-24 |
| 2016-06-30 | $34.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $51.18M derived: sum of 2 quarters · filed 2018-08-24 | $68.68M derived: sum of 3 quarters · filed 2018-08-24 | $80.68M 10-K · filed 2018-08-24 |
| 2016-03-31 | $16.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-05 | $33.70M derived: sum of 2 quarters · filed 2017-05-05 | $45.70M 10-Q · filed 2017-05-05 | $72.57M derived: sum of 4 quarters · filed 2017-08-25 |
| 2015-12-31 | $17.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-03 | $29.50M 10-Q · filed 2017-02-03 | $56.38M derived: sum of 3 quarters · filed 2017-08-25 | $69.38M derived: sum of 4 quarters · filed 2017-08-25 |
| 2015-09-30 | $12.00M 10-Q · filed 2016-11-01 | $38.87M derived: sum of 2 quarters · filed 2017-08-25 | $51.88M derived: sum of 3 quarters · filed 2017-08-25 | $53.83M derived: sum of 4 quarters · filed 2017-08-25 |
| 2015-06-30 | $26.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-25 | $39.88M derived: sum of 2 quarters · filed 2017-08-25 | $41.83M derived: sum of 3 quarters · filed 2017-08-25 | $121.30M 10-K · filed 2017-08-25 |
| 2015-03-31 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-29 | $14.95M derived: sum of 2 quarters · filed 2016-04-29 | $94.42M 10-Q · filed 2016-04-29 | $114.41M derived: sum of 4 quarters · filed 2016-08-24 |
| 2014-12-31 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-01 | $81.42M 10-Q · filed 2016-02-01 | $101.41M derived: sum of 3 quarters · filed 2016-08-24 | $123.17M derived: sum of 4 quarters · filed 2016-08-24 |
| 2014-09-30 | $79.47M 10-Q · filed 2015-11-05 | $99.45M derived: sum of 2 quarters · filed 2016-08-24 | $121.22M derived: sum of 3 quarters · filed 2016-08-24 | $137.20M derived: sum of 4 quarters · filed 2016-08-24 |
| 2014-06-30 | $19.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-24 | $41.75M derived: sum of 2 quarters · filed 2016-08-24 | $57.73M derived: sum of 3 quarters · filed 2016-08-24 | $64.58M 10-K · filed 2016-08-24 |
| 2014-03-31 | $21.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-07 | $37.74M derived: sum of 2 quarters · filed 2015-05-07 | $44.59M 10-Q · filed 2015-05-07 | |
| 2013-12-31 | $15.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | $22.83M 10-Q · filed 2015-02-06 | ||
| 2013-09-30 | $6.85M 10-Q · filed 2014-11-07 | |||
| 2011-06-30 | $85.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $131.49M derived: sum of 2 quarters · filed 2013-08-29 | $152.08M derived: sum of 3 quarters · filed 2013-08-29 | $206.41M 10-K · filed 2013-08-29 |
| 2011-03-31 | $45.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-08 | $66.48M derived: sum of 2 quarters · filed 2012-05-08 | $120.82M 10-Q · filed 2012-05-08 | |
| 2010-12-31 | $20.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-08 | $74.93M 10-Q · filed 2012-02-08 | ||
| 2010-09-30 | $54.34M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $127.09M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |